These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 26649439

  • 21. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
    Lieberman MR, Liebman TN, Alapati U, Khachemoune A.
    Dermatol Online J; 2014 Dec 13; 21(2):. PubMed ID: 25756476
    [Abstract] [Full Text] [Related]

  • 22. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab.
    Stephenson SR, Campbell SM, Drew GS, Magro CM.
    J Cutan Pathol; 2011 Aug 13; 38(8):644-8. PubMed ID: 21592182
    [Abstract] [Full Text] [Related]

  • 23. Neutrophilic dermatosis: disease mechanism and treatment.
    Maalouf D, Battistella M, Bouaziz JD.
    Curr Opin Hematol; 2015 Jan 13; 22(1):23-9. PubMed ID: 25394310
    [Abstract] [Full Text] [Related]

  • 24. Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Tada M, Nakanishi T, Hirata C, Okano T, Sugioka Y, Wakitani S, Nakamura H, Koike T.
    Mod Rheumatol; 2010 Dec 13; 20(6):598-601. PubMed ID: 20680379
    [Abstract] [Full Text] [Related]

  • 25. Occurrence of pulmonary rheumatoid nodules following biological therapies.
    Kovács A, Baksay B, Cserenyecz A, Molnár K, Takács M, Szekanecz Z.
    Clin Rheumatol; 2015 Sep 13; 34(9):1639-42. PubMed ID: 25267563
    [Abstract] [Full Text] [Related]

  • 26. Cutaneous nodules in patients with rheumatoid arthritis: a case report and review of literatures.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Iyama K.
    Clin Rheumatol; 2011 May 13; 30(5):719-22. PubMed ID: 21049278
    [Abstract] [Full Text] [Related]

  • 27. Infliximab induced chilblain lupus in a patient with rheumatoid arthritis.
    Richez C, Dumoulin C, Schaeverbeke T.
    J Rheumatol; 2005 Apr 13; 32(4):760-1. PubMed ID: 15801042
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cutaneous manifestations of malignant disease.
    Higgins EM, du Vivier AW.
    Br J Hosp Med; 2005 Apr 13; 48(9):552-4, 558-61. PubMed ID: 1477711
    [Abstract] [Full Text] [Related]

  • 30. Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules.
    Baeten D, De Keyser F, Veys EM, Theate Y, Houssiau FA, Durez P.
    Ann Rheum Dis; 2004 May 13; 63(5):489-93. PubMed ID: 15082477
    [Abstract] [Full Text] [Related]

  • 31. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
    Deng A, Harvey V, Sina B, Strobel D, Badros A, Junkins-Hopkins JM, Samuels A, Oghilikhan M, Gaspari A.
    Arch Dermatol; 2006 Feb 13; 142(2):198-202. PubMed ID: 16490847
    [Abstract] [Full Text] [Related]

  • 32. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
    Savoia F, Gaddoni G, Casadio C, Spadola G, Patrizi A, Giacomini F, Aldi M.
    G Ital Dermatol Venereol; 2011 Aug 13; 146(4):308-9. PubMed ID: 21785399
    [No Abstract] [Full Text] [Related]

  • 33. [Rheumatoid arthritis: current status of therapy].
    El Bahri DM, Meddeb N, Sellami S.
    Tunis Med; 2007 Jan 13; 85(1):1-8. PubMed ID: 17424701
    [Abstract] [Full Text] [Related]

  • 34. Multiple rheumatoid papules characteristic of the early stage of rheumatoid vasculitis.
    Ikeda E, Uchigasaki S, Baba S, Suzuki H.
    Eur J Dermatol; 1999 Jun 13; 9(4):313-6. PubMed ID: 10356413
    [Abstract] [Full Text] [Related]

  • 35. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.
    Vila AT, Puig L, Fernández-Figueras MT, Laiz AM, Vidal D, Alomar A.
    Br J Dermatol; 2005 Aug 13; 153(2):417-23. PubMed ID: 16086759
    [Abstract] [Full Text] [Related]

  • 36. Inflammatory arthritis and crystal arthropathy: Current concepts of skin and systemic manifestations.
    Fazel M, Merola JF, Kurtzman DJB.
    Clin Dermatol; 2018 Aug 13; 36(4):533-550. PubMed ID: 30047436
    [Abstract] [Full Text] [Related]

  • 37. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review.
    Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ.
    J Am Acad Dermatol; 2009 Sep 13; 61(3):486-504. PubMed ID: 19628303
    [Abstract] [Full Text] [Related]

  • 38. Incidence and classification of cutaneous manifestations in rheumatoid arthritis.
    Ziemer M, Müller AK, Hein G, Oelzner P, Elsner P.
    J Dtsch Dermatol Ges; 2016 Dec 13; 14(12):1237-1246. PubMed ID: 27886444
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.
    Chua-Aguilera CJ, Möller B, Yawalkar N.
    Clin Rev Allergy Immunol; 2017 Dec 13; 53(3):371-393. PubMed ID: 28752373
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.